- Includes 10 leading oncology/translational medicine and drug development experts to support clinical strategy for TR009 and TRIGR's immuno-modulatory bispecific antibody pipeline

IRVINE, CA / ACCESSWIRE, May 13, 2019 - (ACN Newswire) - TRIGR Therapeutics, Inc. ("TRIGR"), a clinical stage biotechnology company focused on the development of...